Jacobio Pharma Presented preliminary Data on BET Inhibitor for Myelofibrosis at 2024 ASH ...Middle East

BEIJING, SHANGHAI and BOSTON, Dec. 8, 2024 /PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company dedicated to developing therapies toward undruggable targets, today presented preliminary Phase I data of BET inhibitor JAB-8263 to treat myelofibrosis (MF) at the 2024...

Hence then, the article about jacobio pharma presented preliminary data on bet inhibitor for myelofibrosis at 2024 ash was published today ( Monday 09/12/2024 - 03:45 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Jacobio Pharma Presented preliminary Data on BET Inhibitor for Myelofibrosis at 2024 ASH )

Also on site :

• Hackers Pose as Microsoft Support to Breach Corporate Defenses .. PYMNTS.com
• BMG to Buy Concord in Major Indie Music Merger
• Why Shashank Singh is not playing today's match vs RR in IPL 2026?